Loratadine

氯雷他定

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameLoratadine
Drug Alias NameLoratidine樂雷塔定乐雷塔定LoratadinumLoratadina +[14] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsDrug-Related Side Effects and Adverse ReactionsChronic UrticariaRhinitis, Allergic +[6] 
Global Approved IndicationsRhinitis, Allergic
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1993/04/12
Country/TerritoryUnited StatesUkraineSweden +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesRutgers UniversityBayer Healthcare Pharmaceuticals LlcShanghai Schering-Plough Pharmaceutical Co Ltd
Inactive CompaniesInstitut D'Investigació Biomèdica De BellvitgeXian Janssen Pharmaceutical LtdUniversity Of Michigan +[5] 
Active IndicationsChronic UrticariaRhinitis, AllergicMultiple Myeloma
Inactive IndicationsDrug-Related Side Effects and Adverse ReactionsBone DiseasesLymphangioleiomyomatosis

Other Information

ATC CodeR06AX13
Related LinksWikipediaDrugBankKEGG